Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

World’s First Conversational Digital Genetic Assistant OptraGURU™ Launches Today From Optra Health

Optra Health
Posted on: 20 Feb 18

Optra Health today announced the introduction of a revolutionary new business solution—OptraGURU™. OptraGuru harnesses vast stores of genetic data locked away in corporate and public data silos, combines it with leading edge artificial intelligence and conversational technologies like Amazon Alexa to give genetic testing organizations the ability to offer a ‘round-the-clock’ personalized and engaging service to their consumers, and more effective tools for their genetic counselors and scientists.

This press release features multimedia. View the full release here:

Genetic testing organizations can deploy OptraGURU™ to their bioinformaticians involved in data analysis to conversationally interrogate raw genetic data. (Photo: Business Wire)

Optra Health will be introducing OptraGURU at the HL7 Genomics Conference in Washington D.C. February 19 – 21st, where Mr. Abhi Gholap, Co-founder and Executive Chairman, will be discussing ‘The Intersection of Artificial Intelligence and Healthcare as it relates to Innovation’.

OptraGuru™ Technology and Amazon Alexa

Consumers have more access to data than ever before which presents potential risks in interpreting complex and often ambiguous information. Genetic Counseling can clear up this ambiguity but may not be readily available when the consumer needs it. OptraGURU™, powered by Optra Health’s iPhronesis™ artificial intelligence platform and its advanced Natural Language Understanding (NLU), and Deep Machine Learning (ML) capabilities, combined with an extensive ontological library of over 65 million unique concepts, provides consumers the ability to access their personal genetic reports via their provider, simply by asking Alexa. Once accessed, using Amazon’s Voice Recognition (VR) and Natural Language Processing (NLP) capabilities, OptraGURU communicates the results in a comprehensive and compassionate manner. Consumers can engage in a conversation with OptraGURU; asking questions and getting detailed answers about their results.

OptraGuru is not limited to consumers—genetic testing organizations can deploy OptraGURU to their genetic counselors engaged in family screening, allowing them to access and compare reports across an entire family and keep up-to-speed with the latest research – ensuring counseling sessions can be more effective. Additionally, OptraGURU can be used by bioinformaticians and scientists involved in data analysis to conversationally interrogate raw data and gather more evidence prior to report generation.

“The convergence of artificial intelligence, conversational technologies like Alexa, and an ever-increasing availability of data is having a transformative effect on how research and clinical results are delivered and communicated,” said Co-founder and CEO Gauri Naik. “The possibilities of using OptraGURU and Ai platforms like iPhronesis™ in combination with extensive public and private data sets, will advance research and improve the consumer experience. We look forward to making OptraGURU accessible to genetic testing organizations that are interested in providing more value through a personalized, digital approach.”

About Optra Health

Optra Health is the leading Data-driven Intelligence Company focused on improving outcomes for leading Life Sciences and Healthcare organizations. By combining our next generation Artificial Intelligence platform iPhronesis, with our team of domain experts, and a passion for solving complex scientific problems we help our clients INNOVATE new products and approaches, ACCELERATE scientific discovery and time-to-market, and OPTIMIZE efficiencies to reduce costs. Get LinkedIn with Optra Health or follow us on Twitter.

View source version on

Business Wire

Last updated on: 20/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.